Annual Retained Earnings
-$155.98 M
-$35.12 M-29.06%
31 December 2023
Summary:
Eliem Therapeutics annual retained earnings is currently -$155.98 million, with the most recent change of -$35.12 million (-29.06%) on 31 December 2023. During the last 3 years, it has fallen by -$127.84 million (-454.38%). ELYM annual retained earnings is now -1988.63% below its all-time high of -$7.47 million, reached on 31 December 2019.ELYM Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$221.46 M
-$8.89 M-4.18%
30 September 2024
Summary:
Eliem Therapeutics quarterly retained earnings is currently -$221.46 million, with the most recent change of -$8.89 million (-4.18%) on 30 September 2024. Over the past year, it has dropped by -$69.12 million (-45.37%). ELYM quarterly retained earnings is now -687.11% below its all-time high of -$28.14 million, reached on 31 December 2020.ELYM Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELYM Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.1% | -45.4% |
| 3 y3 years | -454.4% | -240.3% |
| 5 y5 years | - | - |
ELYM Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -454.4% | at low | -240.3% | at low |
| 5 y | 5 years | -1988.6% | at low | -687.1% | at low |
| alltime | all time | -1988.6% | at low | -687.1% | at low |
Eliem Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$221.46 M(+4.2%) |
| June 2024 | - | -$212.56 M(+34.8%) |
| Mar 2024 | - | -$157.68 M(+1.1%) |
| Dec 2023 | -$155.98 M(+29.1%) | -$155.98 M(+2.4%) |
| Sept 2023 | - | -$152.34 M(+2.7%) |
| June 2023 | - | -$148.37 M(+3.6%) |
| Mar 2023 | - | -$143.15 M(+18.4%) |
| Dec 2022 | -$120.86 M | -$120.86 M(+6.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -$113.10 M(+9.4%) |
| June 2022 | - | -$103.42 M(+16.4%) |
| Mar 2022 | - | -$88.82 M(+17.5%) |
| Dec 2021 | -$75.62 M(+168.8%) | -$75.62 M(+16.2%) |
| Sept 2021 | - | -$65.07 M(+17.3%) |
| June 2021 | - | -$55.46 M(+18.7%) |
| Mar 2021 | - | -$46.74 M(+66.1%) |
| Dec 2020 | -$28.14 M(+276.8%) | -$28.14 M |
| Dec 2019 | -$7.47 M | - |
FAQ
- What is Eliem Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Eliem Therapeutics?
- What is Eliem Therapeutics annual retained earnings year-on-year change?
- What is Eliem Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Eliem Therapeutics?
- What is Eliem Therapeutics quarterly retained earnings year-on-year change?
What is Eliem Therapeutics annual retained earnings?
The current annual retained earnings of ELYM is -$155.98 M
What is the all time high annual retained earnings for Eliem Therapeutics?
Eliem Therapeutics all-time high annual retained earnings is -$7.47 M
What is Eliem Therapeutics annual retained earnings year-on-year change?
Over the past year, ELYM annual retained earnings has changed by -$35.12 M (-29.06%)
What is Eliem Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ELYM is -$221.46 M
What is the all time high quarterly retained earnings for Eliem Therapeutics?
Eliem Therapeutics all-time high quarterly retained earnings is -$28.14 M
What is Eliem Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ELYM quarterly retained earnings has changed by -$69.12 M (-45.37%)